GlassScriptPhysician profile
Ralph B Geiger
NPI 1245294073
$1,678.02
in general payments reported to CMS, 2019-2025
20 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2022: $159 · 2023: $560 · 2024: $488 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.63 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $272.00 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $257.37 | 2019-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $190.98 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $126.86 | 2023-2024 | Otezla, Repatha |
| Exact Sciences Corporation | $113.76 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $108.38 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $94.33 | 2025 | Voquezna |
| Novo Nordisk INC | $81.53 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Almatica Pharma LLC | $71.70 | 2022-2023 | Loreev Xr, Gralise, Sertraline Hcl |
| Dexcom, INC. | $62.36 | 2023-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $61.16 | 2022-2024 | Freestyle Libre 3 |
| Pfizer INC. | $55.57 | 2023-2024 | |
| Amarin Pharma, INC. | $47.71 | 2019 | |
| Daiichi Sankyo INC. | $27.04 | 2022 | |
| Mylan Specialty L.P. | $24.04 | 2023 | Yupelri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $19.24 | 2025 | |
| Medtronic, INC. | $18.28 | 2023 | Percepta Quad Crt-P Mri Surescan |
| Irhythm Technologies, INC. | $15.86 | 2022 | |
| Cashflow Solutions, LLC | $15.72 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Biohaven Pharmaceutical Holding Company LTD. | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.